ClinicalTrials.gg
CompletedNCT07575633Updated Nov 4, 2026

Ultrasound Versus Virtual Reality on Temporomandibular Disorder

An interventional study of ultrasound and virtual reality in Temporomandibular Disorders (TMD), sponsored by Amany Refaat Mohamed Abdel Wahid. Completed at 1 site in Egypt. Open to participants aged 40 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Amany Refaat Mohamed Abdel Wahid · Not applicable, Interventional, and Treatment

Updated Nov 4, 2026Now CompletedFirst site in Egypt+5 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
40 Years to 60 Years
Sex
All
01

Study summary

The Purpose of the study is to compare between the therapeutic efficacy of ultrasound and virtual reality in decreasing pain and improving range of motion (ROM) for patients with temporomandibular joint disorder after tooth extraction surgery.

Read the detailed description

The study will be carried out on patients suffering from temporomandibular joint disorder following tooth extraction surgery. Their ages will range from (40-60) years. They will be randomly divided into two equal groups:

  1. Group A:

    This group will include 25 patients suffering from Timbro Mandibular Joint (TMJ) dysfunction (pain and reduced mouth opening) after tooth extraction. They will receive pulsed ultrasound and traditional manual therapy. The first session of treatment will be 24hr after extraction for three times for one week.

  2. Group B:

This group will include 25 patients suffering from TMJ dysfunction (pain and reduced mouth opening) after tooth extraction. They will receive virtual reality and traditional manual therapy. The first session of treatment will be 24hr after extraction for three times for one week.

02

Conditions studied

  • Temporomandibular Disorders (TMD)

Keywords

  • Temporomandibular disorder
  • Ultrasound
  • Virtual Reality
  • surgery
03

In context

Temporomandibular Joint Disorders

591 studies on the registry are indexed under Temporomandibular Joint Disorders; 149 are open to participants now.

This study's enrollment of 60 is above the median of 45 across 415 interventional studies indexed under Temporomandibular Joint Disorders.

Browse Temporomandibular Joint Disorders studies →

Lead sponsor

Amany Refaat Mohamed Abdel Wahid is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The subject selection will be according to the following criteria:

    • Patients after tooth extraction.
    • Patients from both genders.
    • Patients suffering from pain and reduced mouth opening.
    • Age ranges between 40-60 years.
    • All patients will have .

Exclusion criteria

Exclusion Criteria:

  • . Surgery that conducted on the temporomandibular joint (meniscectomy, arthroscopy, etc.).

    • Patients with systemic disease as diabetes mellitus.
    • Patients with neurological conditions.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    group who will receive ultrasound

    They will receive pulsed ultrasound and traditional manual therapy.

    Device: ultrasound

  • Active comparator
    group who will receive virtual reality

    they will receive virtual reality and traditional manual therapy.

    Device: virtual reality

Interventions

  • Deviceultrasound

    pulsed ultrasound

  • Devicevirtual reality

    Fully Immersive virtual reality (VR)

06

What researchers measure

Primary outcomes

  1. pain free maximum mouth opening (MMO)

    Measured using a millimeter ruler as the maximum interincisal distance (in millimeters) achieved without pain. Participants are instructed to open their mouth as wide as possible without experiencing pain, and the distance between the incisal edges of the upper and lower central incisors is recorded. Scale title: Pain-Free Maximum Mouth Opening (MMO) measured with a millimeter ruler Minimum value: 0 mm Maximum value: No fixed upper limit (typically reported as the measured distance in millimeters) Interpretation: Higher values indicate better mandibular mobility and improved mouth opening.

    Time frame: before and after the treatment (after 1 week)

  2. pain measurement

    Visual Analog Scale (VAS) for Pain: Pain intensity is assessed using a 10-cm Visual Analog Scale, where participants indicate their pain level by marking a point on a horizontal line anchored by "No Pain" at one end and "Worst Imaginable Pain" at the other. Scores range from 0 to 10 cm, with higher scores indicating greater pain intensity and worse outcomes. Scale title: Visual Analog Scale (VAS) for Pain Minimum value: 0 cm (No Pain) Maximum value: 10 cm (Worst Imaginable Pain) Interpretation: Higher scores indicate worse pain (greater pain intensity).

    Time frame: before and after the treatment ( 1 week)

07

Study locations

1 site
  • faculty of physical therapy, Cairo University.
    Giza, 3759914, Egypt
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2026 to primary completion in Jul 2026, 1 month.

Of 242 non-industry interventional studies with no phase under Temporomandibular Joint Disorders, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 21. This study's 1 month is below that.

Counting every sponsor, half of 246 studies reached it within 10 months; a quarter within 5 and three quarters within 21.

How these figures are worked out, and which studies are left out of them.

Registered
May 4, 2026
First posted
May 8, 2026
StartActual
May 4, 2026
Primary completionActual
Jul 1, 2026
CompletionActual
Jul 5, 2026
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Completed
changed Nov 4, 2026
Sites
1 site added — first site in Egypt
Show site
  • faculty of physical therapy, Cairo University. · Giza, Egypt
Nov 4, 2026
Primary completion
Jul 15, 2026→Jul 1, 2026 (actual)
Nov 4, 2026
Study completion
Jul 30, 2026→Jul 5, 2026 (actual)
Nov 4, 2026
Enrollment
50 (estimated)→60 (actual)
Nov 4, 2026
Primary outcomes
2 description edited
What changed in the outcomes
  • Descriptionpain free maximum mouth opening (MMO): how it is measured was reworded
  • Descriptionpain measurement: how it is measured was reworded
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Not yet recruiting→Completed
    1 site added — first site in Egypt
    Show site
    • faculty of physical therapy, Cairo University. · Giza, Egypt
    Primary completion Jul 15, 2026→Jul 1, 2026 (now actual)
    Study completion Jul 30, 2026→Jul 5, 2026 (now actual)
    Enrollment 50 (estimated)→60 (actual)
    Primary outcomes 2 description edited
    What changed in the outcomes
    • Descriptionpain free maximum mouth opening (MMO): how it is measured was reworded
    • Descriptionpain measurement: how it is measured was reworded
    + 4 other changes: verification date, description, arm descriptions and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07575633
Lead sponsor
Amany Refaat Mohamed Abdel Wahid
Collaborators
Cairo University
Responsible party
Amany Refaat Mohamed Abdel Wahid (Lecturer at faculty of physical therapy Cairo University, Cairo University) — Sponsor-investigator
First posted
May 8, 2026
Start date
May 4, 2026
Primary completion
Jul 1, 2026
Completion
Jul 5, 2026
Last update
Nov 4, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion